BLOOD SUBSTITUTES--MOLECULAR AND PHYSIOLOGICAL ASPECTS
BLOOD SUBSTITUTES--MOLECULAR AND PHYSIOLOGICAL ASPECTS
批准号:
2519336
负责人:
Robert M Winslow
金额:
$83.63万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-01 至 1998-08-31
中文摘要
这个计划的假设是细胞自由
英文摘要
The hypothesis underlying this Program Project is that cell free
hemoglobin, suitably modified by structural engineering, will be safe and
effective therapy in many clinical situations where red blood cells are
indicated. The main goal of the Program Project is to understand the
physiological consequences and clinical potential of replacement of red
blood cells in the circulation with acellular blood substitutes.
Expertise in design, production and testing of new solutions, with
academic expertise in several key areas of biochemistry, physiology,
molecular biology and clinical medicine will be brought together under
this Program Project to focus on specific problems of large scale
infusions of acellular red cell substitutes, while simultaneously
exploiting emerging technology to shed new light on basic physiological
and biochemical problems. The elements of the Program Project reflect the
interests of the UCSD faculty, rather than a comprehensive approach to
development of blood substitutes. However, the expertise is broad and
deep, and nearly all relevant areas will be studied. Core A will
coordinate activities of the component projects and cores, manage budget,
purchasing, scheduling of meetings and seminars, and provide basic
secretarial support. Core B will produce or obtain materials representing
various classes of products under development for investigation by the
various projects, including both hemoglobin- and perflurocarbon-based
oxygen carries; some will be produced in the Program Project, and others
will be obtained from other laboratories. The in vitro ligand binding,
stability and toxicity will be related to protein structure in Project
1, and the effects on the microcirculation will be studied in Project 2,
the heart in Project 3, the kidney in Project 4. Data obtained in these
projects will be used in Project 1 for the design of new chemically
modified or (by collaboration) mutant derivatives of hemoglobin using
computer visualization techniques in Project 1. Each project will have
advisors from the UCSD faculty. An executive committee made up of the
principal investigators from each project and core that has met monthly
for the last year will form the nucleus of a group and will continue to
share data, results, and plans for future studies. Internal and external
advisory groups of outstanding scientists will be appointed to provide
expertise in related fields.
期刊论文(52)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
alphaalpha-crosslinked hemoglobin: was failure predicted by preclinical testing?
αα交联血红蛋白:临床前测试是否预测失败?
DOI:
10.1159/000031200
发表时间:
2000
期刊:
Vox sanguinis
影响因子:
2.7
作者:
[Winslow,RM]
通讯作者:
Winslow,RM
Examples of chemical modification and recombinant DNA approaches with hemoglobin.
使用血红蛋白进行化学修饰和重组 DNA 方法的示例。
DOI:
10.1016/s1246-7820(96)80026-7
发表时间:
1996
期刊:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.
影响因子:
--
作者:
[Manning,JM]
通讯作者:
Manning,JM
Subunit dissociations in natural and recombinant hemoglobins.
天然和重组血红蛋白中的亚基解离。
DOI:
10.1002/pro.5560050423
发表时间:
1996
期刊:
Protein science : a publication of the Protein Society.
影响因子:
--
作者:
[Manning,LR, Jenkins,WT, Hess,JR, Vandegriff,K, Winslow,RM, Manning,JM]
通讯作者:
Manning,JM
Potential role of luminal potassium in tubuloglomerular feedback.
管腔钾在肾小管肾小球反馈中的潜在作用。
DOI:
10.1681/asn.v8121831
发表时间:
1997
期刊:
Journal of the American Society of Nephrology : JASN
影响因子:
--
作者:
[Vallon,V, Osswald,H, Blantz,RC, Thomson,S]
通讯作者:
Thomson,S
Luminal signal in tubuloglomerular feedback: what about potassium?
肾小球反馈中的管腔信号:钾怎么样?
DOI:
10.1046/j.1523-1755.1998.06739.x
发表时间:
1998
期刊:
Kidney international. Supplement
影响因子:
--
作者:
[Vallon,V, Osswald,H, Blantz,RC, Thomson,S]
通讯作者:
Thomson,S
共 30 条
OXYGEN TRANSPORT CYS CELL FREE HEMOGLOBIN
-
批准号:6080433
-
项目类别:
-
资助金额:$35.48万
-
财政年份:1999
-
负责人:Robert M Winslow
-
依托单位:
OXYGEN TRANSPORT CYS CELL FREE HEMOGLOBIN
-
批准号:6184925
-
项目类别:
-
资助金额:$33.89万
-
财政年份:1999
-
负责人:Robert M Winslow
-
依托单位:
OXYGEN TRANSPORT CYS CELL FREE HEMOGLOBIN
-
批准号:6537758
-
项目类别:
-
资助金额:$35.42万
-
财政年份:1999
-
负责人:Robert M Winslow
-
依托单位:
OXYGEN TRANSPORT CYS CELL FREE HEMOGLOBIN
-
批准号:6390672
-
项目类别:
-
资助金额:$34.98万
-
财政年份:1999
-
负责人:Robert M Winslow
-
依托单位:
PHYSIOLOGICAL PROPERTIES OF MODIFIED HEMOGLOBIN
-
批准号:6110134
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:Robert M Winslow
-
依托单位:
CORE--PRODUCTION FACILITY
-
批准号:6110137
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:Robert M Winslow
-
依托单位:
BLOOD SUBSTITUTES--MOLECULAR AND PHYSIOLOGICAL ASPECTS
-
批准号:2224061
-
项目类别:
-
资助金额:$78.72万
-
财政年份:1993
-
负责人:Robert M Winslow
-
依托单位:
BLOOD SUBSTITUTES--MOLECULAR AND PHYSIOLOGICAL ASPECTS
-
批准号:2224062
-
项目类别:
-
资助金额:$78.31万
-
财政年份:1993
-
负责人:Robert M Winslow
-
依托单位:
BLOOD SUBSTITUTES--MOLECULAR AND PHYSIOLOGICAL ASPECTS
-
批准号:2224063
-
项目类别:
-
资助金额:$80.92万
-
财政年份:1993
-
负责人:Robert M Winslow
-
依托单位:
BLOOD SUBSTITUTES--MOLECULAR AND PHYSIOLOGICAL ASPECTS
-
批准号:3098885
-
项目类别:
-
资助金额:$95.94万
-
财政年份:1993
-
负责人:Robert M Winslow
-
依托单位:
海外基金